BRK-B vs GGZ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating significant fundamental weakness or structural misalignment with standard corporate health metrics. However, the trust appears fundamentally undervalued, trading at $16.17 against an intrinsic value of $20.79 and a very low P/E of 5.44. While long-term price performance is strong (1Y +44.3%), the current technical trend is heavily bearish (10/100). The conflict between poor deterministic health scores and strong value/performance metrics necessitates a neutral stance.
Compare Another Pair
Related Comparisons
BRK-B vs GGZ: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and The Gabelli Global Small and Mid Cap Value Trust (GGZ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.